ArriVent Biopharma’s $155M Series B Financing

Mintz represented ArriVent Biopharma, Inc. on the deal.ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155 Million…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now